Stay updated on Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. It indicates a minor update to the page without changing the core study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-03-08T01:48:38.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now displays revision v3.4.2; the previous revision v3.4.1 has been removed.
    Difference
    0.0%
    Check dated 2026-02-14T08:22:45.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.1, replacing the previous Revision: v3.4.0.
    Difference
    0.0%
    Check dated 2026-02-07T06:10:30.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Added UI/metadata updates: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-24T00:57:15.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces v3.3.3 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-16T23:53:42.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Location information updated: a new Locations heading appears and specific state sites (Georgia, Illinois, New Jersey, New York) are listed. State-specific subsections were removed, and the revision updated to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-19T13:59:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.